Skip to content
thestock.space

QMS Medical Allied Services (QMSMEDI) had a P/E of 28.6× on 6 Nov 2026, in line with the industry P/E of 28.6×, and the shares are 22% below their 52-week high. It earns ROCE of 18% and ROE of 10%, and sales and net profit grew 18% and 17% a year over 3 years. Its dividend yield is 0.3%, and debt is 0.65× equity. It is a small-cap company with a market cap of ₹326 Cr, ranked 7th of 11 Medical Instruments & Supplies companies by market cap; the shares rose 75% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹171.00
Day high
₹171.00
Day low
₹164.50
Prev. close
₹169.84
Volume
15.7K

Health check

2 good · 4 fair
  • ReturnsAhead

    +75.0% over a year, better than 6 of 7 peers.

  • Price tagIn line

    P/E 28.6 vs industry 28.6.

  • GrowthSteady

    Sales +18.4%, profit +16.7% a year over 3 years.

  • ProfitabilityAverage

    ROCE 18.4% vs peer median 11.5%.

  • Balance sheetFair

    Debt 0.65× equity, interest covered 3.8×, Piotroski 4 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Small cap

₹326 Cr, #7 of 11 in its industry by size.

Defensive

Beta 0.66 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹183 Cr · profit ₹11 Cr
Market cap
₹326 Cr
Small cap
P/E
28.6
Industry 28.6
Price to book
5.68
Peers 4.44
Dividend yield
0.30%
ROE
10.5%
Peers 11.0%
ROCE
18.4%
Peers 11.5%
Debt to equity
0.65
Debt ₹74 Cr
EPS (TTM)
₹5.89
Face value ₹10
OPM (TTM)
15.1%
Net margin 5.9%
Sales growth
+22.3%
Latest quarter vs a year ago
Profit growth
+24.7%
Latest quarter vs a year ago
Price to sales
1.78
EV/EBITDA 13.8

Strengths and risks

Strengths

  • Quarterly profit up 24.7% on a year ago.
  • Quarterly sales up 22.3% on a year ago.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About QMS Medical Allied Services

QMS Medical Allied Services Limited distributes medical and healthcare products in India. The company also offers BP monitors, stethoscopes, surgical sterilization kits, BMI scales, and orthotics, as well as Q-Devices; and point-of-care testing devices, rapid diagnostic kits, and in-clinic multipara devices. It also operates QMSMEDS, an e-commerce platform that sells healthcare devices of various brands. In addition, the company provides patient support…

Headquarters
Mumbai
Employees
1,037
Sector
Healthcare
ISIN
INE0FMW01018
Website
qmsmas.com

Price range

52 weeks

₹68.95₹216.79

Today

₹164.50₹171.00
Avg volume (3M)
52.2K
1-year return
plus 75.0%
From 52-week high
minus 22.2%

Peers · Medical Instruments & Supplies

Compare with peersScreen the whole industry
Company
LENSKARTLenskart Solutions724.75plus 0.89%1,25,562160.713.487.2%6.7%20.8%––0.00%plus 79.8%
AGARWALEYEDr. Agarwal's Health Care516.35plus 0.91%16,37394.17.669.7%6.8%15.0%26.9%12.3%0.00%minus 0.7%
POLYMEDPoly Medicure1,612.30plus 0.63%16,34351.45.2613.3%11.0%15.2%18.8%21.6%0.22%minus 18.1%
TARSONSTarsons Products316.95minus 0.46%1,686151.72.644.8%2.3%−0.9%14.3%−43.8%0.00%plus 10.9%
LAXMIDENTLLaxmi Dental196.42minus 0.05%1,08134.84.4411.5%12.8%16.4%19.5%–0.00%minus 37.9%
PREVESTPrevest Denpro397.85minus 3.85%47822.03.8321.9%17.8%34.8%12.4%9.3%0.25%minus 21.2%
QMSMEDIQMS Medical Allied Services168.66minus 0.69%32628.65.6818.4%10.5%12.0%18.4%16.7%0.30%plus 75.0%
SHREEPACShree Pacetronix170.00plus 0.32%6419.53.4125.0%19.7%24.8%2.2%−1.2%0.00%minus 38.5%
Median of 7 peers–0.32%1,68651.44.4411.5%11.0%16.4%16.6%9.3%0.00%−18.1%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
46.544.737.344.456.9
4037.830.538.748.6
6.56.96.75.88.3
14.1%15.5%18.1%13.0%14.6%
0.30.20.30.20.4
1.41.41.721.7
0.90.911.11.5
4.54.84.32.85.5
29.6%26.2%25.8%29.0%28.7%
2.93.13.223.6
2.201.711.240.892.05

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+18.4%
Profit CAGR 3Y
+16.7%
EPS CAGR 3Y
+11.9%
ROE
10.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
104122156173
–+17.4%+27.7%+10.8%
92.6104130147
11.418.325.626.2
11.0%15.0%16.4%15.2%
0.40.51.60.4
23.14.55.9
1.13.43.83.9
−0.1–−0.1−0.3
8.712.218.716.4
26.7%26.4%26.6%27.5%
6.4912.110.1
–+41.1%+34.3%minus 16.2%
3.864.986.655.40

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
17.917.917.919.3
52.660.771.984.9
25.534.560.374.5
21.822.34034.2
118135190213
25.123.42322.9
–0.1––
2.42.44.36.7
90.3109163183
118135190213

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−7.51.419.219.4
−25.1−2.7−45.5−20.4
31.70.426.81.1
−0.9−10.50.1
−1.7−2.6−3.4−5.8
−9.21.419.219.4
–−0.9−0.9−0.9

Shareholding pattern

Source: NSE filings
68.1%
promoters
  • Promoters68.11%
  • Public31.89%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202668.11%31.89%0.00
30 Jun 202668.11%31.89%0.00
31 Mar 202668.11%31.89%0.00
30 Sep 202568.11%31.89%plus 0.04
23 Sep 202568.07%31.93%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you